Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16302825rdf:typepubmed:Citationlld:pubmed
pubmed-article:16302825lifeskim:mentionsumls-concept:C0031330lld:lifeskim
pubmed-article:16302825lifeskim:mentionsumls-concept:C0064219lld:lifeskim
pubmed-article:16302825lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:16302825lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:16302825lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:16302825lifeskim:mentionsumls-concept:C0682002lld:lifeskim
pubmed-article:16302825lifeskim:mentionsumls-concept:C0148753lld:lifeskim
pubmed-article:16302825lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:16302825pubmed:issue24lld:pubmed
pubmed-article:16302825pubmed:dateCreated2005-11-23lld:pubmed
pubmed-article:16302825pubmed:abstractTextThe natural product willardiine (8) is an AMPA receptor agonist while 5-iodowillardiine (10) is a selective kainate receptor agonist. In an attempt to produce antagonists of kainate and AMPA receptors analogues of willardiine with substituents at the N3 position of the uracil ring were synthesized. The N3-4-carboxybenzyl substituted analogue (38c) was found to be equipotent at AMPA and GLUK5-containing kainate receptors in the neonatal rat spinal cord. The N3-2-carboxybenzyl substituted analogue (38a) proved to be a potent and selective GLUK5 subunit containing kainate receptor antagonist when tested on native rat and human recombinant AMPA and kainate receptor subtypes. The GLUK5 kainate receptor antagonist activity was found to reside in the S enantiomer (44a) whereas the R enantiomer (44b) was almost inactive. 5-Iodo substitution of the uracil ring of 44a gave 45, which was found to have enhanced potency and selectivity for GLUK5.lld:pubmed
pubmed-article:16302825pubmed:languageenglld:pubmed
pubmed-article:16302825pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:citationSubsetIMlld:pubmed
pubmed-article:16302825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16302825pubmed:statusMEDLINElld:pubmed
pubmed-article:16302825pubmed:monthDeclld:pubmed
pubmed-article:16302825pubmed:issn0022-2623lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:CollingridgeG...lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:BortolottoZun...lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:RobertsPeter...lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:BleakmanDavid...lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:MoreJulia C...lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:TroopHelen...lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:JaneDavid EDElld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:DolmanNigel...lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:NisticoRobert...lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:MorleyRichard...lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:AltAndrewAlld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:KnaussJody...lld:pubmed
pubmed-article:16302825pubmed:authorpubmed-author:JackSamanthaSlld:pubmed
pubmed-article:16302825pubmed:issnTypePrintlld:pubmed
pubmed-article:16302825pubmed:day1lld:pubmed
pubmed-article:16302825pubmed:volume48lld:pubmed
pubmed-article:16302825pubmed:ownerNLMlld:pubmed
pubmed-article:16302825pubmed:authorsCompleteYlld:pubmed
pubmed-article:16302825pubmed:pagination7867-81lld:pubmed
pubmed-article:16302825pubmed:dateRevised2010-1-13lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:meshHeadingpubmed-meshheading:16302825...lld:pubmed
pubmed-article:16302825pubmed:year2005lld:pubmed
pubmed-article:16302825pubmed:articleTitleSynthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.lld:pubmed
pubmed-article:16302825pubmed:affiliationDepartment of Pharmacology, MRC Centre for Synaptic Plasticity, School of Medical Sciences, University Walk, University of Bristol, Bristol, BS8 1TD, UK.lld:pubmed
pubmed-article:16302825pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16302825pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:16302825pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:16302825lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16302825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16302825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16302825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16302825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16302825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16302825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16302825lld:pubmed